Serum proteo-metabolome profile in the stage of CRC progression
Abstract
The primary objective of this investigation is to discover putative serum biomarkers indicative of disease progression from ulcerative colitis to colorectal carcinoma through combined analysis of proteomic and metabolomic signatures. Accordingly, 208 individuals were recruited as the discovery cohort and 101 as the validation cohort. Serum samples were collected from all participants for high-throughput proteomic profiling and untargeted metabolomic analysis.
Fields of Study & Subjects
Metabolomics and Mass Spectrometry Studies
Inflammatory Bowel Disease
Advanced Proteomics Techniques and Applications
Publication details
- Journal / source
- China National GeneBank DataBase
- Publication date
- 1 January 2026
- Language
- EN